We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Laser-Based Method to Accelerate Cancer Diagnosis

By LabMedica International staff writers
Posted on 02 Apr 2025
Print article
Image: The new method can help accelerate the diagnosis of oncological diseases (Photo courtesy of Vilnius University)
Image: The new method can help accelerate the diagnosis of oncological diseases (Photo courtesy of Vilnius University)

Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published in Scientific Reports, describes how to quickly and accurately analyze the structure of collagen in tissue.

Scientists from the Faculty of Physics and the Life Sciences Center at Vilnius University (Vilnius, Lithuania), in collaboration with others, explain that this method, known as Double Stokes polarimetry, relies on how collagen responds to laser light that is polarized in different ways. By measuring the polarization, the method reveals the ultrastructural parameters of collagen, which detail its molecular structure. This allows for the evaluation of changes in collagen structure that occur during various diseases.

Similar approaches have already been applied to study tissues from breast and lung cancer, among other cancers, as well as conditions like keratoconus. These changes in collagen structure are closely linked to disease progression and symptoms. A key benefit of this method is its speed, which is several hundred times faster than other comparable techniques. This makes it particularly suitable for use in clinical settings. The research team plans to continue exploring this method and will apply it to analyze both cancerous tissue and samples from other diseases.

"This work can significantly contribute to the development of oncological and histopathological diagnostics," said Prof. Dr. Virginijus Barzda. “We hope that this method will allow physicians to more effectively detect subtle tissue changes. Collagen is the most common protein in the human body, so investigation of its structure would allow for more accurate disease diagnostics.”

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.